Inventor · disambiguated record
Norihisa Ohtake
Also filed as: OHTAKE NORIHISA
3 granted patents·8 pending applications·2 citations·filing 2015–2021
53Inventor score
Technology areasG01N
Top patents by PatentIndex Score
11 records- 0172US11193936B2Method and reagent for detecting ovarian clear cell adenocarcinomaPUBLIC UNIV CORP YOKOHAMA CITY UNIV·Filed 2019·Granted Dec 7, 2021·1 cites·4 claims
- 0268US11913955B2Methods for detecting cancers, and detecting reagentTOSOH CORP·Filed 2018·Granted Feb 27, 2024·1 cites·9 claims
- 0350US11604194B2Method for detecting castration-resistant prostate cancer and detection reagentPUBLIC UNIV CORP YOKOHAMA CITY UNIV·Filed 2017·Granted Mar 14, 2023·0 cites·11 claims
- 0447US2023221322A1Method and reagent for detecting pancreatic cancersPUBLIC UNIV CORP YOKOHAMA CITY UNIV·Filed 2021·Application pending·0 cites
- 0546US2022178932A1Cancer detection method and detection reagentJAPANESE FOUND FOR CANCER RES·Filed 2020·Application pending·0 cites
- 0645US2017322218A1Method and reagent for detecting ovarian clear cell adenocarcinomaPUBLIC UNIV CORP YOKOHAMA CITY UNIV·Filed 2015·Application pending·0 cites
- 0744US2023053846A1Method for detecting cancer bone metastasis and detection reagentUNIV OSAKA·Filed 2020·Application pending·0 cites
- 0844US2024053363A1Biomarker for determining fertility, and determining method using samePUBLIC UNIV CORP YOKOHAMA CITY UNIV·Filed 2021·Application pending·0 cites
- 0942US2023047882A1Method for detecting protein in extracellular vesicles and extracellular vesicle membrane permeabilization treatment agentTOSOH CORP·Filed 2020·Application pending·0 cites
- 1040US2021063400A1Renal cancer detection method and test drugPUBLIC UNIV CORP YOKOHAMA CITY UNIV·Filed 2018·Application pending·0 cites
- 1132US2019049464A1Blood biomarker for detecting arteriosclerosisPUBLIC UNIV CORP YOKOHAMA CITY UNIV·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Norihisa Ohtake files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →